PubRank

Hongyue Dai

Author PubWeight™ 213.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002 71.36
2 A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002 58.15
3 Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 2005 10.85
4 Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007 6.43
5 Rosetta error model for gene expression analysis. Bioinformatics 2006 4.67
6 Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics 2004 4.09
7 Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 2012 4.07
8 Effects of atmospheric ozone on microarray data quality. Anal Chem 2003 3.93
9 Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A 2006 3.70
10 Microarray standard data set and figures of merit for comparing data processing methods and experiment designs. Bioinformatics 2003 3.33
11 MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009 3.07
12 Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res 2013 2.12
13 A protocol for building and evaluating predictors of disease state based on microarray data. Bioinformatics 2005 2.08
14 EMT is the dominant program in human colon cancer. BMC Med Genomics 2011 2.05
15 T lymphocyte activation gene identification by coregulated expression on DNA microarrays. Genomics 2004 1.86
16 Expression profiling predicts outcome in breast cancer. Breast Cancer Res 2002 1.81
17 microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 2010 1.69
18 Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int 2011 1.60
19 Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res 2005 1.56
20 A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors. BMC Med Genomics 2010 1.50
21 Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 2009 1.49
22 Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004 1.44
23 DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 2011 1.40
24 Characterization of globin RNA interference in gene expression profiling of whole-blood samples. Clin Chem 2007 1.39
25 Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature. BMC Cancer 2008 1.37
26 Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol 2011 1.36
27 Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 2009 1.32
28 MicroRNA-like off-target transcript regulation by siRNAs is species specific. RNA 2009 1.27
29 Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol 2012 1.27
30 Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS One 2011 1.26
31 Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma. Int J Cancer 2010 1.08
32 Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin. J Mol Endocrinol 2009 1.06
33 Inferring causal genomic alterations in breast cancer using gene expression data. BMC Syst Biol 2011 1.06
34 A microarray platform comparison for neuroscience applications. J Neurosci Methods 2004 1.01
35 Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets. PLoS Genet 2012 0.98
36 Diurnal variation of the human adipose transcriptome and the link to metabolic disease. BMC Med Genomics 2009 0.97
37 Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma. OMICS 2011 0.90
38 Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling. Mol Cancer Ther 2005 0.87
39 TF-centered downstream gene set enrichment analysis: Inference of causal regulators by integrating TF-DNA interactions and protein post-translational modifications information. BMC Bioinformatics 2010 0.85
40 The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma. Int J Comput Biol Drug Des 2011 0.85
41 Development of a microarray platform for FFPET profiling: application to the classification of human tumors. J Transl Med 2009 0.84
42 Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS One 2011 0.83
43 Development of an approach for ab initio estimation of compound-induced liver injury based on global gene transcriptional profiles. Genome Inform 2006 0.82
44 Chromosome 20q amplification regulates in vitro response to Kinesin-5 inhibitor. Cancer Inform 2008 0.80
45 A survey of cancer cell lines reveals highly structured and hierarchical relationships within and between DNA and mRNA that may be the result of selection. OMICS 2010 0.80
46 Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists. Mol Pharmacol 2012 0.79
47 Clinicopathologic and gene expression parameters predict liver cancer prognosis. BMC Cancer 2011 0.78
48 PPARalpha siRNA-treated expression profiles uncover the causal sufficiency network for compound-induced liver hypertrophy. PLoS Comput Biol 2007 0.78
49 Accelerating drug discovery: Open source cancer cell biology? Cancer Cell 2006 0.77